KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$152.4 million.

  • Gsk's Short-term Investments fell 14868.32% to -$152.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$152.4 million, marking a year-over-year decrease of 14868.32%. This contributed to the annual value of -$245.4 million for FY2024, which is 10895.27% down from last year.
  • Latest data reveals that Gsk reported Short-term Investments of -$152.4 million as of Q3 2025, which was down 14868.32% from $266.8 million recorded in Q2 2025.
  • Over the past 5 years, Gsk's Short-term Investments peaked at $4.8 billion during Q4 2022, and registered a low of -$383.0 million during Q3 2022.
  • In the last 5 years, Gsk's Short-term Investments had a median value of $148.7 million in 2021 and averaged $478.2 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 24321.75% in 2022, then soared by 63919.99% in 2023.
  • Gsk's Short-term Investments (Quarter) stood at $267.4 million in 2021, then surged by 1692.43% to $4.8 billion in 2022, then plummeted by 42.94% to $2.7 billion in 2023, then tumbled by 109.01% to -$246.4 million in 2024, then surged by 38.14% to -$152.4 million in 2025.
  • Its Short-term Investments was -$152.4 million in Q3 2025, compared to $266.8 million in Q2 2025 and $119.7 million in Q1 2025.